HB Portfolio Q2 FY26: Sharp Profit Collapse Amid Revenue Volatility Raises Concerns

Nov 12 2025 09:48 AM IST
share
Share Via
HB Portfolio Limited, a micro-cap non-banking financial company engaged in investment in securities, reported a dramatic collapse in consolidated net profit for Q2 FY26, plunging 96.33% quarter-on-quarter to ₹0.08 crores from ₹2.18 crores in Q1 FY26. On a year-on-year basis, the profit declined 80.00% from ₹0.40 crores in Q2 FY25. The company, with a market capitalisation of ₹85.00 crores, has seen its stock price tumble 29.86% over the past year, currently trading at ₹75.82, significantly below all key moving averages and reflecting mounting investor concerns about the sustainability of its business model.





Net Profit (Q2 FY26)

₹0.08 Cr

▼ 96.33% QoQ



Revenue (Q2 FY26)

₹3.93 Cr

▼ 48.96% QoQ



Operating Margin

3.82%

vs 46.88% in Q1



ROE (Average)

1.61%

Weak capital efficiency




The quarter's results paint a troubling picture of extreme volatility and operational challenges. Revenue declined sharply from ₹7.70 crores in Q1 FY26 to ₹3.93 crores, whilst operating profit margin collapsed from 46.88% to a mere 3.82%. This dramatic swing in profitability, coupled with persistently weak return on equity of just 1.61%, raises serious questions about the company's ability to generate consistent returns for shareholders.



The stock has been in a mildly bearish technical trend since October 31, 2025, trading below all major moving averages including the critical 200-day moving average at ₹88.32. With institutional holdings at a negligible 0.03% and the company sporting a "Strong Sell" rating with a score of just 13 out of 100, market sentiment remains decidedly negative.



Quarterly Performance Trend: A Pattern of Instability









































































Quarter Revenue (₹ Cr) QoQ Change Net Profit (₹ Cr) QoQ Change Operating Margin
Sep'25 (Q2 FY26) ₹3.93 -48.96% ₹0.08 -96.33% 3.82%
Jun'25 (Q1 FY26) ₹7.70 +79.07% ₹2.18 -171.24% 46.88%
Mar'25 (Q4 FY25) ₹4.30 -55.81% -₹3.06 +255.81% -43.26%
Dec'24 (Q3 FY25) ₹9.73 +92.29% -₹0.86 -315.00% -5.76%
Sep'24 (Q2 FY25) ₹5.06 -42.17% ₹0.40 -88.47% 4.74%
Jun'24 (Q1 FY25) ₹8.75 -76.55% ₹3.47 +128.29% 54.97%
Mar'24 (Q4 FY24) ₹37.32 ₹1.52 1.90%



The quarterly trend reveals alarming inconsistency. Revenue has swung wildly between ₹3.93 crores and ₹37.32 crores over the past seven quarters, whilst profitability has oscillated between losses and profits with no discernible pattern. This volatility suggests either a business model heavily dependent on market timing or fundamental operational challenges in generating stable income streams.



Financial Performance: Margin Compression and Earnings Quality Concerns



The most striking feature of Q2 FY26 results is the dramatic margin compression. Operating profit excluding other income stood at just ₹0.15 crores, representing a margin of 3.82%, down from 46.88% in the previous quarter. This 43-percentage-point collapse in margins occurred despite employee costs remaining relatively stable at ₹2.41 crores compared to ₹2.65 crores in Q1 FY26.





Revenue (Q2 FY26)

₹3.93 Cr

▼ 48.96% QoQ | ▼ 22.33% YoY



Net Profit (Q2 FY26)

₹0.08 Cr

▼ 96.33% QoQ | ▼ 80.00% YoY



Operating Margin (Excl OI)

3.82%

vs 46.88% in Q1 FY26



PAT Margin

0.00%

vs 27.66% in Q1 FY26




The tax expense in Q2 FY26 showed an unusual 100.00% tax rate, effectively wiping out the minimal pre-tax profit of ₹0.02 crores. This resulted in a standalone net profit of ₹0.00 crores, though consolidated profit managed ₹0.08 crores. The quality of earnings remains questionable given the extreme volatility and lack of consistent operating cash generation.



On a half-yearly basis (H1 FY26), the company reported consolidated net profit of ₹2.26 crores, representing a 41.60% decline compared to the corresponding period. Revenue for H1 FY26 stood at ₹11.63 crores, down significantly from previous periods, indicating structural challenges in the business.




Critical Earnings Quality Issues


The company's earnings exhibit severe volatility with no consistent pattern. Operating margins have swung from 54.97% to -43.26% across quarters, whilst profitability has alternated between substantial profits and losses. This inconsistency, combined with a weak average ROE of 1.61%, suggests fundamental challenges in capital allocation and business sustainability. The minimal other income contribution and high employee cost base relative to revenue further constrain profitability.




Operational Challenges: Weak Returns and Balance Sheet Concerns



HB Portfolio's operational metrics paint a concerning picture of capital inefficiency. The company's average return on equity (ROE) of just 1.61% ranks amongst the weakest in its peer group and falls far short of the cost of capital. The latest ROE stands at a dismal -0.02%, indicating the company is actually destroying shareholder value rather than creating it. This poor return profile reflects either inadequate asset deployment or a flawed business model.



The return on capital employed (ROCE) fares marginally better at 0.67%, but remains woefully inadequate for an investment company. These anaemic returns suggest the company's investment portfolio is either poorly constructed, suffering from market headwinds, or facing structural challenges in generating adequate income.



From a balance sheet perspective, the company maintains shareholder funds of ₹276.52 crores as of March 2025, comprising share capital of ₹11.04 crores and reserves of ₹265.48 crores. However, reserves declined from ₹274.83 crores in March 2024, reflecting the losses incurred during FY25. Investments stood at ₹181.25 crores, down from ₹202.71 crores the previous year, suggesting either market value erosion or strategic divestments.




Capital Efficiency Red Flag


With an average ROE of 1.61% and latest ROE of -0.02%, HB Portfolio is failing to generate meaningful returns on shareholder capital. For context, even a risk-free government bond yields significantly more than the company's ROE. This fundamental weakness in capital efficiency represents the core challenge facing investors and raises questions about management's ability to allocate capital effectively in its investment portfolio.




Peer Comparison: Lagging on Key Metrics

























































Company P/E Ratio P/BV Ratio ROE (%) Dividend Yield Debt to Equity
HB Portfolio NA (Loss Making) 0.29x 1.61% 1.33% 0.00
Banas Finance NA (Loss Making) 0.45x 22.06% 0.00
Advik Capital 11.83x 0.48x 18.26% 0.84
Pioneer Invest 9.99x 0.53x 2.55% 0.93
Mukesh Babu Fin. 55.39x 0.26x 2.78% 1.02% 0.13



HB Portfolio's peer comparison reveals significant underperformance on critical metrics. Whilst the company trades at the lowest price-to-book ratio of 0.29x amongst peers, this discount appears justified given its abysmal ROE of 1.61% compared to peers like Banas Finance (22.06%) and Advik Capital (18.26%). The company's inability to generate profits results in an undefined P/E ratio, placing it in the "loss-making" category alongside Banas Finance.



The company does maintain a competitive dividend yield of 1.33%, having paid ₹1.00 per share, but this appears unsustainable given the current profit trajectory. With zero debt, HB Portfolio maintains a clean balance sheet, but this conservative capital structure has not translated into superior returns, suggesting missed opportunities for productive leverage.



Valuation Analysis: Expensive Despite Discount to Book



Despite trading at just 0.29x book value, HB Portfolio carries a "Very Expensive" valuation grade according to proprietary metrics. This seemingly contradictory assessment reflects the company's inability to generate adequate returns on its book value. The enterprise value to EBITDA multiple of 52.19x and EV to EBIT of 74.63x appear stretched given the operational challenges and margin volatility.





P/E Ratio (TTM)

NA

Loss Making



Price to Book Value

0.29x

vs Industry avg



Dividend Yield

1.33%

₹1.00 per share



EV/EBITDA

52.19x

Elevated multiple




The stock has declined 38.13% from its 52-week high of ₹122.55, currently trading near its 52-week low of ₹71.70. The valuation grade changed to "Very Expensive" from "Attractive" on May 27, 2025, reflecting deteriorating fundamentals. At current levels, the stock offers no margin of safety despite the discount to book value, as the underlying business struggles to generate consistent profits.




"A low price-to-book ratio means nothing when the book value itself generates negligible returns. HB Portfolio's 1.61% ROE renders its 0.29x P/BV ratio a value trap rather than a value opportunity."


Shareholding Pattern: Stable But Uninspiring

























































Category Sep'25 Jun'25 Mar'25 Dec'24 QoQ Change
Promoter 61.45% 61.45% 61.45% 61.45% 0.00%
FII 0.00% 0.00% 0.00% 0.00% 0.00%
Mutual Funds 0.01% 0.01% 0.01% 0.01% 0.00%
Other DII 0.01% 0.01% 0.01% 0.01% 0.00%
Non-Institutional 38.53% 38.53% 38.53% 38.53% 0.00%



The shareholding pattern reveals a completely static structure with promoter holding steady at 61.45% and no institutional interest whatsoever. With just 0.03% total institutional holdings and only eight mutual funds holding minuscule positions, the stock lacks institutional backing. This absence of sophisticated investor interest reflects the company's weak fundamentals and limited growth prospects.



The lack of any movement in shareholding patterns over multiple quarters suggests minimal trading interest and poor liquidity. Promoter Lalit Bhasin holds 58.76% directly, with no pledging of shares, indicating at least financial stability at the promoter level. However, the complete absence of FII participation and negligible mutual fund interest speaks volumes about institutional confidence—or lack thereof—in the company's prospects.



Stock Performance: Severe Underperformance Across Timeframes































































Period Stock Return Sensex Return Alpha
1 Week -2.09% +1.22% -3.31%
1 Month -2.78% +2.40% -5.18%
3 Months -10.39% +5.29% -15.68%
6 Months -17.77% +2.48% -20.25%
YTD -28.03% +8.11% -36.14%
1 Year -29.86% +7.38% -37.24%
3 Years +117.87% +36.71% +81.16%
5 Years +369.47% +94.84% +274.63%



HB Portfolio's stock performance tells a tale of two distinct periods. Whilst long-term holders have enjoyed spectacular returns—369.47% over five years and 117.87% over three years—recent performance has been catastrophic. The stock has plunged 29.86% over the past year, underperforming the Sensex by a massive 37.24 percentage points. Year-to-date returns of -28.03% compare poorly against the Sensex's +8.11% gain, resulting in negative alpha of 36.14%.



The stock trades below all major moving averages, including the 5-day (₹76.33), 20-day (₹76.61), 50-day (₹77.23), 100-day (₹83.62), and 200-day (₹88.32) averages. This technical configuration suggests sustained selling pressure with no immediate support levels in sight. The stock's beta of 1.50 indicates high volatility, amplifying market movements in both directions.



With a risk-adjusted return of -0.63 over the past year and volatility of 47.71%, the stock falls squarely into the "High Risk Low Return" category. The negative Sharpe ratio confirms that investors are not being compensated for the substantial risk they are bearing. The NBFC sector has returned 21.33% over the past year, making HB Portfolio's -29.86% return an underperformance of 51.19 percentage points relative to its peer group.



Investment Thesis: Multiple Red Flags Dominate





Valuation Grade

Very Expensive



Quality Grade

Below Average



Financial Trend

Negative



Technical Trend

Mildly Bearish




The investment thesis for HB Portfolio is overwhelmingly negative across all key parameters. The company scores just 13 out of 100 on proprietary metrics, firmly in "Strong Sell" territory. Every critical dimension—valuation, quality, financial trend, and technicals—flashes warning signals.



Key Strengths & Risk Factors





KEY STRENGTHS



  • Zero Debt: Clean balance sheet with no financial leverage provides financial flexibility

  • Long-term Track Record: Five-year returns of 369.47% demonstrate historical wealth creation capability

  • Stable Promoter Holding: 61.45% promoter stake with no pledging indicates promoter confidence

  • Dividend Payment: Maintains 1.33% dividend yield despite operational challenges

  • Established Presence: Operating since 1994 with experience in financial services and investment management




KEY CONCERNS



  • Abysmal ROE: 1.61% average ROE indicates severe capital inefficiency and value destruction

  • Extreme Volatility: Quarterly profits swing wildly from losses to profits with no consistency

  • Margin Collapse: Operating margins crashed from 46.88% to 3.82% in a single quarter

  • Negative Trend: Financial trend classified as "Negative" with deteriorating metrics across periods

  • Zero Institutional Interest: Just 0.03% institutional holdings reflects lack of sophisticated investor confidence

  • Technical Weakness: Trading below all moving averages in mildly bearish trend

  • Severe Underperformance: -29.86% one-year return versus +21.33% sector return





Outlook: What to Watch





POSITIVE CATALYSTS



  • Sustainable improvement in operating margins above 15% for two consecutive quarters

  • ROE improvement to above 8-10% demonstrating better capital allocation

  • Consistent quarterly profitability without wild swings

  • Institutional investor participation increasing above 2-3%

  • Revenue stabilisation with predictable income streams




RED FLAGS



  • Further margin compression below 3% levels

  • Continuation of quarterly profit volatility and losses

  • ROE remaining below 2% for multiple quarters

  • Stock breaking below ₹71.70 (52-week low)

  • Declining book value due to sustained losses

  • Any increase in debt without corresponding improvement in returns





The path forward for HB Portfolio requires fundamental transformation. The company must demonstrate consistent profitability, stabilise margins, and dramatically improve capital efficiency. Until these changes materialise, the stock remains a speculative bet with substantial downside risk and limited near-term catalysts for improvement.




The Verdict: Avoid This Value Trap


STRONG SELL

Score: 13/100


For Fresh Investors: Stay away. The combination of weak ROE (1.61%), extreme earnings volatility, negative financial trend, and bearish technicals creates a perfect storm of risk factors. The discount to book value is a value trap, not a value opportunity, given the company's inability to generate adequate returns on that book value. Better opportunities exist elsewhere in the NBFC space with stronger fundamentals and consistent performance.


For Existing Holders: Consider exiting on any relief rally. The stock has declined 29.86% over the past year and shows no signs of stabilisation. With all major parameters—valuation, quality, financial trend, and technicals—flashing red, the risk-reward equation remains unfavourable. The company's historical five-year outperformance appears to be a distant memory as current operational challenges mount. Use any bounce towards ₹80-85 levels as an exit opportunity.


Fair Value Estimate: ₹65-70 (10-15% downside from current levels) based on 0.25-0.27x P/BV multiple justified by weak ROE profile and operational challenges.





Note— ROCE = (EBIT - Other income)/(Capital Employed - Cash - Current Investments)





⚠️ Investment Disclaimer


This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. Stock investments carry risk of loss, including potential loss of principal invested.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is HB Portfolio falling/rising?
Dec 02 2025 12:53 AM IST
share
Share Via
Why is HB Portfolio falling/rising?
Nov 18 2025 11:09 PM IST
share
Share Via
Has HB Portfolio declared dividend?
Nov 13 2025 11:31 PM IST
share
Share Via